Savings and support for your patients with bleeding disorders

Novo Nordisk is committed to helping you support your patients throughout their treatment. Help your patients with hemophilia or rare bleeding disorders save on their treatment with a copay card. 

support

Savings and support for your patients with bleeding disorders

Novo Nordisk is committed to helping you support your patients throughout their treatment. Help your patients with hemophilia or rare bleeding disorders save on their treatment with a copay card.

Help patients save

If your patients have commercial insurance, they may be eligible for a lower copay with a savings card. Here patients can activate, request, or print their card.

Direct your patients to NovoFactorSavings.com.

Help patients save

If your patients have commercial insurance, they may be eligible for a lower copay with a savings card. Here patients can activate, request, or print their card.

Direct your patients to NovoFactorSavings.com.

Product Assistance Program (PAP) 

Eligible patients who do not have prescription coverage may be able to get their treatment free of charge through the Novo Nordisk Hemophilia and Rare Bleeding Disorders PAP. No registration or monthly fees are required.

Product Assistance Program (PAP) 

Eligible patients who do not have prescription coverage may be able to get their treatment free of charge through the Novo Nordisk Hemophilia and Rare Bleeding Disorders PAP. No registration or monthly fees are required.

Patient trial program

Commercially insured patients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product may be eligible to receive a limited supply for free.

Patient trial program

Commercially insured patients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product may be eligible to receive a limited supply for free.

Novo Nordisk is committed to supporting the bleeding disorders community    

Novo Nordisk is committed to supporting the bleeding disorders community    

Esperoct®, Novoeight®, NovoSeven®, Rebinyn®, and Tretten® are registered trademarks of Novo Nordisk Health Care AG.
NovoCare® is a registered trademark of Novo Nordisk A/S.    
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2022 Novo Nordisk  All rights reserved. US21NC00016  May 2022